The First Digital International Panda Festival Opens on November 3, 2020 in Meishan, China
3.11.2020 20:00:00 EET | Business Wire | Press release
With the theme of "Panda World, World Panda--For Nature As It Is", the first digital International Panda Festival is hosted by Sichuan Forestry and Grassland Administration (Giant Panda National Park Sichuan Administration), Information Office of Sichuan Provincial People's Government, Sichuan Foreign Affairs Office, Sichuan Internet Information Office, International Union for Conservation of Nature (IUCN) China Representative Office, organized by Sichuan Digital Panda Technology Development Co., Ltd., co-organized by Sichuan Provincial People's Association for Friendship with Foreign Countries, Chengdu Research Base of Giant Panda Breeding and Sichuan Giant Panda Protection Foundation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201103005025/en/
The First Digital International Panda Festival (Photo: Business Wire)
Giant pandas are the "messenger of peace" in China's opening to the outside world. Sichuan ranks first in the area of giant panda habitat, the number of wild giant panda population and captive giant pandas in China.
Sichuan, as one of the pilot areas of the Giant Panda National Park, covers an area of 20,177 square kilometers, accounting for 74.36%. There are 1,227 giant pandas in the wild, accounting for 75.23%.
The opening ceremony launches a “space-air-ground-man” integrated digital platform. Locals will be able to learn about the life of Sichuan-based giant pandas living in foreign countries. Meanwhile, it releases books such as the Gift of Nature - Discovering Sichuan as It Is, Landscape of Bamboo forests in Sichuan, Secret Sichuan - the 88 Most Beautiful Forest and Grass Landscapes to Go. It also releases the top six lists of “the Most Beautiful Bamboo Landscape” in Chengdu-Chongqing Economic Circle, as well as the Guidelines on Promoting the Development of Natural Education by eight departments including Sichuan Provincial Forestry and Grassland Administration, Sichuan Provincial Development and Reform Commission, Education Department of Sichuan Province, etc. Besides, Forest and Grassland Fire Research Institute, Sichuan Academy of Forestry Sciences are inaugurated.
Six forums and three conferences systematically present successful experiences in building high-quality forest and grassland fire barriers. Exhibitions such as the Nature Reserve Photo Exhibition, the Giant Panda Cultural and Creative Exhibition, and the Giant Panda International Art Exhibition make you appreciate the unique charm.
The digital International Panda Festival will strive to develop into a branded network exchange platform with distinctive themes at both national and international levels, making itself the only global flagship platform with western characteristics in China.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201103005025/en/
Contact information
Media Contact
Sichuan Digital Panda Technology Development Co., Ltd.
Name: Tina Tian
Email: digitalpanda@digitalgiantpanda.com
Websites: http://www.digitalgiantpanda.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom